insights_auto
Why is NOVA up ၂.၄၇%?
Dive Deeperchevron_right
NOVA:FRA
Novo Nordisk A/S
၃၄.၀၄ €
arrow_upward
+၂.၄၇%(+၀.၈၂) 1D
အောက် ၇, GMT+၂ ၂၂:၀၀:၀၀ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVA...
Open
၃၃.၁၆ €
High
၃၄.၀၄ €
Low
၃၂.၉၄ €
Mkt. cap
ဋေ ၁.၂၇ သ
Avg. vol.
၁.၂၈ ထောင်
Volume
၈၉၈.၀၀
52-wk high
၅၄.၈၀ €
52-wk low
၃၀.၄၅ €
No. of employees
၇ သောင်း
Open
၃၃.၁၆ €
High
၃၄.၀၄ €
Low
၃၂.၉၄ €
Mkt. cap
ဋေ ၁.၂၇ သ
Avg. vol.
၁.၂၈ ထောင်
Volume
၈၉၈.၀၀
52-wk high
၅၄.၈၀ €
52-wk low
၃၀.၄၅ €
No. of employees
၇ သောင်း
News stories
From web sources and news partners
Traders Union
·
ပြီးခဲ့သည့် ၆ နာရီ
Novo Nordisk shares gain more than 2% after ongoing buyback program and cost-saving measures
The Motley Fool
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?
TipRanks
·
ပြီးခဲ့သည့် ၁ ရက်
Novo Nordisk Probes Patient Priorities in German Hemophilia A Study
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
Profile
Novo is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark's domestic economy, and it became the highest valued company in Europe. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees၆.၆၇ သောင်း
Founded၁၉၂၃ ဒီ ၂၁
HeadquartersBagsværd, Capital Region of Denmark, ဒိန်းမတ်
Sector-
Websitenovonordisk.com